Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial

AIMS: Dual antiplatelet therapy reduces non-fatal ischaemic events after acute coronary syndrome (ACS) but increases bleeding to a similar extent. We sought to determine the prognostic impact of myocardial infarction (MI) vs. bleeding during an extended follow-up period to gain insight into the trad...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur Heart J
Päätekijät: Valgimigli, Marco, Costa, Francesco, Lokhnygina, Yuliya, Clare, Robert M., Wallentin, Lars, Moliterno, David J., Armstrong, Paul W., White, Harvey D., Held, Claes, Aylward, Philip E., Van de Werf, Frans, Harrington, Robert A., Mahaffey, Kenneth W., Tricoci, Pierluigi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2017
Aiheet:
Clinical Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837470/
https://ncbi.nlm.nih.gov/pubmed/28363222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehw525
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia